We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 60 start-ups with an aggregate funding of $9.9b. The average funding per company in this subset is $165.5m.
Last update to the database: Feb 18, 2025. See changelog.
Arzeda is a biotechnology and software company designing custom microorganisms for industrial applications through computational enzyme design, protein optimization, and metabolic engineering.
5
Funding Rounds
$72.2m
Money raised
Bolt Threads is a biotechnology company that makes high performance fabrics and materials using biology.
8
Funding Rounds
$406.4m
Money raised
Apeel Sciences is a company that develops treatments to prevent spoilage of fruits and vegetables using molecules naturally found in peels, which maintain moisture and keep out oxygen.
21
Funding Rounds
$1.9b
Money raised
Aria Pharmaceuticals is a first-in-class pharmaceutical discovery and development founded in 2014 by Andrew M. Radin.
3
Funding Rounds
$14.3m
Money raised
Genomatica is a San Diego-based company founded in 2000 by Christophe Schilling.
10
Funding Rounds
$635.4m
Money raised
DNA synthesis company using enzymatic DNA synthesis based in San Francisco.
4
Funding Rounds
$87.8m
Money raised
Fortify is a Boston-based 3D printing company that has the goal to enable fabrication of composites with optimized microstructures
5
Funding Rounds
$32.5m
Money raised
Genapsys is a company developing DNA sequencing technologies and systems founded in 2010 by Hesaam Esfandyarpour.
10
Funding Rounds
$402.1m
Money raised
Dewpoint Therapeutics is a US-based drug manufacturing company.
4
Funding Rounds
$364.1m
Money raised
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.
4
Funding Rounds
$226.0m
Money raised
Cayman Chemical Company is an Ann Arbor, Michigan-based biotechnology company manufacturing healthcare and research diagnostic tools including assay kits, antibodies, proteins, and biochemicals.
1
Funding Rounds
$1.5m
Money raised
Engine Biosciences is a San Francisco-based AI company that is focused on drugs development.
2
Funding Rounds
$53.0m
Money raised
Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics.
4
Funding Rounds
$249.5m
Money raised
Contraline is a company developing contraceptive for men founded in 2015 by Kevin Eisenfrats.
1
Funding Rounds
$10.0m
Money raised
Empirico Inc. comprises of biologists, physicians, chemists, data scientists and drug developers whose focus is on transforming patients' lives with innovative therapies.
2
Funding Rounds
$29.5m
Money raised
BioAge Labs focuses on developing AI and systems biology-based solutions for slowing the aging process and treating age-related illnesses.
3
Funding Rounds
$123.9m
Money raised
Casma Therapeutics is a company that has a research community and uses its understanding of research to develop novel therapeutics to capture disease causing targets.
3
Funding Rounds
$108.9m
Money raised
GenEdit develops technology for gene editing.
3
Funding Rounds
$34.5m
Money raised
A biotechnology company developing drugs for the treatment of metabolic diseases, cancer and inflammation
4
Funding Rounds
$223.5m
Money raised
DiaCarta is a Richmond, California-based molecular diagnostics company developing products for translational genomics and personalized diagnostics founded in 2011 by Aiguo Zhang.
2
Funding Rounds
$53.0m
Money raised
Cellarity is a company that develops medicines by understanding cell behaviors.
3
Funding Rounds
$294.0m
Money raised
Avitide discovers, develops, manufactures, and supplies custom and catalog biopharmaceutical affinity purification solutions to the biopharmaceutical industry.
7
Funding Rounds
$40.6m
Money raised
Small molecule compounds that act by unlocking protein-protein interfaces
2
Funding Rounds
$140.0m
Money raised
A company that develops molecular imaging agents to detect and monitor chronic human diseases
4
Funding Rounds
$69.9m
Money raised
A company that provides services and technologies for the development and commercialization of biopharmaceutical products
2
Funding Rounds
$20.0m
Money raised
Small Molecules Acting on Stem Cells. Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
6
Funding Rounds
$799.0m
Money raised
Ceres Nanosciences is a sample Prep Technology founded in 2008.
2
Funding Rounds
$3.0m
Money raised
Centrillion Technologies is a company that develops genomic and bioinformatic tools and services that analyze technology for personalized medicine and life sciences research.
7
Funding Rounds
$58.8m
Money raised
A company developing application-specific coatings and medical devices for the orthopedic and cardiovascular fields
1
Funding Rounds
$3.0m
Money raised
Expansion Therapeutics is a RNA Targeted Small Molecules founded in 2016.
2
Funding Rounds
$135.3m
Money raised
Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.
3
Funding Rounds
$331.0m
Money raised
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
3
Funding Rounds
$351.0m
Money raised
Escient Pharmaceuticals is a GPCR-targeted Drugs founded in 2018.
4
Funding Rounds
$312.5m
Money raised
Eikon Therapeutics is developing a new method of drug discovery based on tracking and measuring the movement of individual proteins in live cells.
2
Funding Rounds
$666.0m
Money raised
BCD Bioscience is a Davis, California-based biotechnology company developing ingredients for food, agriculture, and biopharmaceutical applications.
2
Funding Rounds
$16.8m
Money raised
Cygnal Therapeutics is an exoneural biology company.
1
Funding Rounds
$65.0m
Money raised
Apostle Inc is a Sunnyvale, California-based company providing technologies and services for public health and life sciences.
2
Funding Rounds
$5.7m
Money raised
Cedilla Therapeutics is a company founded in 2018.
4
Funding Rounds
$256.2m
Money raised
A company focused on developing products for oncology surgery and therapeutic intervention
3
Funding Rounds
$34.5m
Money raised
Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment.
2
Funding Rounds
$2.5m
Money raised
Element Biosciences is a genetic analysis tools.
2
Funding Rounds
$291.0m
Money raised
Accent Therapeutics is a RNA-modifying protein inhibitors founded in 2017 by Robert Copeland.
2
Funding Rounds
$103.0m
Money raised
Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins
2
Funding Rounds
$92.2m
Money raised
DeepCure is an AI Drug Discovery founded by Joseph Jacobson, Kfir Schreiber and Thrasyvoulos (Thras) Karydis.
1
Funding Rounds
$40.0m
Money raised
BrightVolt is a Redmond, Washington-based company.
2
Funding Rounds
$34.1m
Money raised
Ambys Medicines is a liver cell, gene, drug therapies founded in 2018.
1
Funding Rounds
$140.0m
Money raised
BridGene Biosciences is a small molecules that drug traditionally undruggable targets.
1
Funding Rounds
$12.0m
Money raised
2
Funding Rounds
$115.0m
Money raised
ADARx is developing a RNA targeting platform focused on genetic, cardiometabolic and central nervous system diseases
1
Funding Rounds
$75.0m
Money raised
Celsee Diagnostics is a Plymouth, Michigan-based diagnostics company developing single-cell and liquid biopsy products.
3
Funding Rounds
$10.2m
Money raised
Blade Therapeutics is a fibrosis Treatments.
2
Funding Rounds
$95.0m
Money raised
Exo Therapeutics is a small Molecule Drug Discovery.
1
Funding Rounds
$78.0m
Money raised
1
Funding Rounds
$6.8m
Money raised
Anokion is an immune-tolerated therapeutic proteins founded by Melody Swartz.
2
Funding Rounds
$80.0m
Money raised
Anagenex is a directed Evolution Platform for Small Molecule Discovery founded in 2019.
1
Funding Rounds
$30.0m
Money raised
Boragen is a United States-based company.
1
Funding Rounds
$10.0m
Money raised
Civetta Therapeutics is a small molecule targeting of beta-propeller domains founded in 2019.
1
Funding Rounds
$53.0m
Money raised
DeTect is a company founded by Hugo Barra.
1
Funding Rounds
$3.3m
Money raised
Autobahn Therapeutics is a remyelination program for multiple sclerosis.
1
Funding Rounds
$76.0m
Money raised
Advenchen Laboratories is a small Molecules founded in 2003.
1
Funding Rounds
$4.5m
Money raised